Evolus IncNASDAQ:EOLS
- LAST PRICE10.8500
- TODAY'S CHANGE (%)-0.0800 (-0.7319%)
- Bid / Lots10.4100/ 10
- Ask / Lots11.0200/ 5
- Open / Previous Close11.0000 / 10.9300
- Day Range
- 52 Week Range
- Volume2,369,968
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EOLS |
|---|---|---|
| 09:32 ET | 2846 | 10.9 |
| 09:34 ET | 170 | 11 |
| 09:36 ET | 10100 | 10.93 |
| 09:38 ET | 100 | 10.93 |
| 09:39 ET | 13490 | 10.86 |
| 09:41 ET | 341 | 10.87 |
| 09:43 ET | 615 | 10.86 |
| 09:48 ET | 500 | 10.78 |
| 09:52 ET | 1800 | 10.75 |
| 09:56 ET | 251 | 10.735 |
| 09:57 ET | 200 | 10.76 |
| 09:59 ET | 100 | 10.765 |
| 10:01 ET | 200 | 10.825 |
| 10:03 ET | 444 | 10.82 |
| 10:06 ET | 1200 | 10.83 |
| 10:10 ET | 3245 | 10.85 |
| 10:14 ET | 900 | 10.86 |
| 10:15 ET | 418 | 10.87 |
| 10:17 ET | 1300 | 10.88 |
| 10:19 ET | 1503 | 10.89 |
| 10:21 ET | 200 | 10.88 |
| 10:26 ET | 400 | 10.89 |
| 10:28 ET | 400 | 10.9 |
| 10:30 ET | 3456 | 10.93 |
| 10:32 ET | 700 | 10.92 |
| 10:33 ET | 1254 | 10.9 |
| 10:35 ET | 400 | 10.89 |
| 10:37 ET | 4987 | 10.87 |
| 10:39 ET | 200 | 10.87 |
| 10:42 ET | 100 | 10.87 |
| 10:44 ET | 307 | 10.865 |
| 10:46 ET | 100 | 10.855 |
| 10:48 ET | 1357 | 10.845 |
| 10:51 ET | 700 | 10.82 |
| 10:55 ET | 500 | 10.815 |
| 10:57 ET | 2205 | 10.81 |
| 11:02 ET | 705 | 10.8 |
| 11:04 ET | 735 | 10.79 |
| 11:06 ET | 711 | 10.79 |
| 11:08 ET | 200 | 10.79 |
| 11:09 ET | 100 | 10.785 |
| 11:11 ET | 957 | 10.77 |
| 11:13 ET | 200 | 10.77 |
| 11:15 ET | 300 | 10.77 |
| 11:18 ET | 400 | 10.76 |
| 11:20 ET | 200 | 10.76 |
| 11:24 ET | 500 | 10.78 |
| 11:27 ET | 409 | 10.77 |
| 11:31 ET | 1350 | 10.77 |
| 11:33 ET | 675 | 10.77 |
| 11:36 ET | 100 | 10.77 |
| 11:38 ET | 831 | 10.76 |
| 11:40 ET | 400 | 10.765 |
| 11:42 ET | 300 | 10.76 |
| 11:44 ET | 744 | 10.75 |
| 11:47 ET | 900 | 10.73 |
| 11:49 ET | 109 | 10.73 |
| 11:51 ET | 200 | 10.72 |
| 11:54 ET | 100 | 10.73 |
| 11:58 ET | 1527 | 10.75 |
| 12:00 ET | 200 | 10.76 |
| 12:02 ET | 610 | 10.75 |
| 12:03 ET | 1143 | 10.75 |
| 12:05 ET | 1503 | 10.74 |
| 12:07 ET | 605 | 10.73 |
| 12:09 ET | 1269 | 10.72 |
| 12:12 ET | 1975 | 10.72 |
| 12:14 ET | 200 | 10.72 |
| 12:16 ET | 910 | 10.71 |
| 12:18 ET | 200 | 10.71 |
| 12:20 ET | 3122 | 10.71 |
| 12:21 ET | 300 | 10.72 |
| 12:25 ET | 1600 | 10.74 |
| 12:27 ET | 600 | 10.75 |
| 12:30 ET | 1100 | 10.77 |
| 12:32 ET | 606 | 10.76 |
| 12:34 ET | 100 | 10.775 |
| 12:36 ET | 200 | 10.78 |
| 12:38 ET | 500 | 10.78 |
| 12:39 ET | 774 | 10.77 |
| 12:41 ET | 750 | 10.77 |
| 12:43 ET | 200 | 10.775 |
| 12:45 ET | 100 | 10.775 |
| 12:48 ET | 1289 | 10.78 |
| 12:50 ET | 100 | 10.78 |
| 12:54 ET | 100 | 10.77 |
| 12:57 ET | 800 | 10.77 |
| 01:01 ET | 530 | 10.78 |
| 01:03 ET | 962 | 10.78 |
| 01:06 ET | 1000 | 10.83 |
| 01:08 ET | 3433 | 10.83 |
| 01:10 ET | 100 | 10.835 |
| 01:14 ET | 700 | 10.84 |
| 01:15 ET | 1228 | 10.83 |
| 01:17 ET | 200 | 10.83 |
| 01:21 ET | 1213 | 10.82 |
| 01:26 ET | 300 | 10.81 |
| 01:28 ET | 616 | 10.81 |
| 01:30 ET | 959 | 10.8 |
| 01:32 ET | 887 | 10.79 |
| 01:33 ET | 707 | 10.76 |
| 01:35 ET | 327 | 10.74 |
| 01:37 ET | 2462 | 10.73 |
| 01:39 ET | 792 | 10.73 |
| 01:42 ET | 300 | 10.71 |
| 01:46 ET | 794 | 10.74 |
| 01:48 ET | 200 | 10.75 |
| 01:50 ET | 100 | 10.74 |
| 01:51 ET | 601 | 10.74 |
| 01:53 ET | 1053 | 10.73 |
| 01:55 ET | 300 | 10.73 |
| 01:57 ET | 100 | 10.73 |
| 02:00 ET | 1020 | 10.73 |
| 02:02 ET | 501 | 10.73 |
| 02:04 ET | 100 | 10.73 |
| 02:06 ET | 1800 | 10.76 |
| 02:08 ET | 1854 | 10.755 |
| 02:09 ET | 200 | 10.75 |
| 02:11 ET | 200 | 10.75 |
| 02:13 ET | 100 | 10.75 |
| 02:15 ET | 700 | 10.77 |
| 02:18 ET | 827 | 10.75 |
| 02:20 ET | 1100 | 10.76 |
| 02:22 ET | 15373 | 10.71 |
| 02:24 ET | 2100 | 10.72 |
| 02:26 ET | 100 | 10.71 |
| 02:27 ET | 300 | 10.73 |
| 02:29 ET | 700 | 10.73 |
| 02:31 ET | 100 | 10.73 |
| 02:33 ET | 619 | 10.72 |
| 02:36 ET | 200 | 10.72 |
| 02:40 ET | 600 | 10.73 |
| 02:42 ET | 400 | 10.72 |
| 02:44 ET | 788 | 10.72 |
| 02:45 ET | 1145 | 10.71 |
| 02:49 ET | 100 | 10.71 |
| 02:54 ET | 200 | 10.7 |
| 02:56 ET | 2800 | 10.67 |
| 02:58 ET | 2253 | 10.7 |
| 03:00 ET | 1400 | 10.71 |
| 03:02 ET | 100 | 10.7 |
| 03:03 ET | 1700 | 10.7 |
| 03:05 ET | 3286 | 10.7 |
| 03:07 ET | 1400 | 10.72 |
| 03:09 ET | 200 | 10.73 |
| 03:12 ET | 615 | 10.72 |
| 03:14 ET | 470 | 10.71 |
| 03:16 ET | 758 | 10.71 |
| 03:18 ET | 300 | 10.69 |
| 03:20 ET | 1737 | 10.71 |
| 03:21 ET | 900 | 10.7 |
| 03:23 ET | 349 | 10.69 |
| 03:25 ET | 300 | 10.71 |
| 03:27 ET | 200 | 10.69 |
| 03:30 ET | 2419 | 10.72 |
| 03:32 ET | 4200 | 10.71 |
| 03:34 ET | 1400 | 10.71 |
| 03:36 ET | 1914 | 10.74 |
| 03:38 ET | 300 | 10.75 |
| 03:39 ET | 2648 | 10.74 |
| 03:41 ET | 747 | 10.75 |
| 03:43 ET | 901 | 10.74 |
| 03:45 ET | 2628 | 10.74 |
| 03:48 ET | 2665 | 10.725 |
| 03:50 ET | 1869 | 10.73 |
| 03:52 ET | 8306 | 10.825 |
| 03:54 ET | 23151 | 10.83 |
| 03:56 ET | 7095 | 10.82 |
| 03:57 ET | 13377 | 10.835 |
| 03:59 ET | 23421 | 10.85 |
Jun 24, 2024
Jun 12, 2024
Evolus Broadens International Presence with Launch of Nuceiva(R) (botulinum toxin type A) in Spain, from 8:00AM ET on Wednesday Jun 12, 2024 by Dow Jones
8:00AM ET on Wednesday Jun 12, 2024 by Dow Jones
Jun 7, 2024
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 5:00PM ET on Friday Jun 07, 2024 by Dow Jones
5:00PM ET on Friday Jun 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Evolus Inc | 679.3M | -10.4x | --- |
Harrow Inc | 739.1M | -23.0x | --- |
SIGA Technologies Inc | 539.8M | 6.9x | -28.78% |
Xeris Biopharma Holdings Inc | 333.6M | -4.8x | --- |
Takeda Pharmaceutical Co Ltd | 41.0B | 45.6x | -8.01% |
LifeVantage Corp | 81.5M | 23.0x | -16.83% |
Company Information
Evolus, Inc. is a performance beauty company. Its primary market is the cash-pay aesthetic market, which consists of medical products. Its product candidates include Jeuveau and Evolysse. Jeuveau is its commercially available proprietary 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Jeuveau offers a 900kDa botulinum toxin alternative to BOTOX (onabotulinumtoxinA). Jeuveau is available in the United States, Canada, and European markets. Evolysse is a line of hyaluronic acid dermal fillers which utilizes first-generation cold technology in regulatory development. The line includes a variety of products, including mid face, nasolabial folds, lips and eyes in the United States and Europe. Its product candidates represent two of the product categories within medical aesthetics, injectable neurotoxins, and injectable dermal fillers.
Contact Information
- Headquarters
- 520 Newport Center Dr Ste 1200NEWPORT BEACH, CA, United States 92660-7022
- Phone
- 949-284-4555
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vikram Malik
- President, Chief Executive Officer, Director
- David Moatazedi
- Chief Financial Officer
- Sandra Beaver
- Chief Marketing Officer
- Tomoko Yamagishi-Dressler
- Chief Medical Officer, Head - Research and Development
- Rui Avelar
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $679.3M |
|---|---|
Revenue (TTM) | $219.7M |
Shares Outstanding | 62.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.29 |
EPS | $-1.05 |
Book Value | $-0.36 |
P/E Ratio | -10.4x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20.99% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
